TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
TG Therapeutics (NASDAQ: TGTX) announced that Chairman and CEO Michael S. Weiss will participate in the TD Cowen Immunology & Inflammation Summit, a virtual event running November 12–13, 2025. The company said the fireside chat is scheduled for Wednesday, November 12, 2025 at 10:00 AM ET. A live webcast will be available on the company’s Investors & Media Events page at http://ir.tgtherapeutics.com/events. The presentation offers investors an opportunity to hear management commentary and participate via the live webcast.
TG Therapeutics (NASDAQ: TGTX) ha annunciato che il Presidente e CEO Michael S. Weiss parteciperà al TD Cowen Immunology & Inflammation Summit, un evento virtuale che si svolgerà dall'12 al 13 novembre 2025. La chiacchierata informale è prevista per mercoledì 12 novembre 2025 alle 10:00 ET. Una trasmissione in diretta sarà disponibile sulla pagina degli Investitori & Media Events dell'azienda all'indirizzo http://ir.tgtherapeutics.com/events. La presentazione offre agli investitori l'opportunità di ascoltare i commenti della direzione e di partecipare tramite la trasmissione in diretta.
TG Therapeutics (NASDAQ: TGTX) anunció que el presidente y director ejecutivo Michael S. Weiss participará en la TD Cowen Immunology & Inflammation Summit, un evento virtual que se llevará a cabo los días 12 y 13 de noviembre de 2025. La charla junto a la chimenea está prevista para miércoles 12 de noviembre de 2025 a las 10:00 a. m. hora del Este. Una transmisión en vivo estará disponible en la página de Eventos de Inversores y Medios de la empresa en http://ir.tgtherapeutics.com/events. La presentación ofrece a los inversores la oportunidad de escuchar comentarios de la dirección y participar vía la transmisión en vivo.
TG Therapeutics (NASDAQ: TGTX)가 의장 겸 최고경영자 Michael S. Weiss가 TD Cowen Immunology & Inflammation Summit에 참여할 것이라고 발표했습니다. 이는 2025년 11월 12일~13일에 열리는 가상 행사입니다. 파이어사이드 챗은 2025년 11월 12일 수요일 오전 10:00 동부 표준시로 예정되어 있습니다. 라이브 생중계는 회사의 Investors & Media Events 페이지 http://ir.tgtherapeutics.com/events에서 이용 가능합니다. 발표 내용은 투자자들에게 경영진의 코멘트를 듣고 라이브 방송을 통해 참여할 기회를 제공합니다.
TG Therapeutics (NASDAQ : TGTX) a annoncé que le président-directeur général Michael S. Weiss participera au TD Cowen Immunology & Inflammation Summit, un événement virtuel qui se déroulera du 12 au 13 novembre 2025. La discussion au coin du feu est prévue pour le mercredi 12 novembre 2025 à 10h00, heure de l'Est. Une diffusion en direct sera disponible sur la page Événements Investisseurs & Médias de l'entreprise à l'adresse http://ir.tgtherapeutics.com/events. La présentation offre aux investisseurs l'occasion d'entendre les commentaires de la direction et de participer via la diffusion en direct.
TG Therapeutics (NASDAQ: TGTX) gab bekannt, dass der Vorsitzende und CEO Michael S. Weiss am TD Cowen Immunology & Inflammation Summit teilnehmen wird, einer virtuellen Veranstaltung, die am 12. und 13. November 2025 stattfindet. Das Fireside-Chat ist für Mittwoch, den 12. November 2025 um 10:00 Uhr ET vorgesehen. Eine Live-Webcast wird auf der Seite des Unternehmens Investors & Media Events unter http://ir.tgtherapeutics.com/events verfügbar sein. Die Präsentation bietet Investoren die Möglichkeit, Managementkommentare zu hören und über das Live-Streaming teilzunehmen.
TG Therapeutics (NASDAQ: TGTX) أعلنت أن رئيس مجلس الإدارة والمدير التنفيذي Michael S. Weiss سيشارك في TD Cowen Immunology & Inflammation Summit، وهو حدث افتراضي سيُعقد في 12–13 نوفمبر 2025. سيتم إجراء دردشة أمام المدفأة يوم الأربعاء 12 نوفمبر 2025 الساعة 10:00 صباحًا بتوقيت شرق الولايات المتحدة. ستتوفر بث مباشر على صفحة فعاليات المستثمرين والإعلام للشركة على http://ir.tgtherapeutics.com/events. تقدم العرض للمستثمرين فرصة سماع تعليقات الإدارة والمشاركة عبر البث المباشر.
- None.
- None.
Fireside chat scheduled for Wednesday November 12, 2025 at 10:00 AM ET
NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the TD Cowen Immunology & Inflammation Summit, which is taking place virtually from November 12 – 13, 2025. The fireside chat is scheduled to take place on Wednesday, November 12, 2025, at 10:00 AM ET.
A live webcast of the fireside chat will be available on the Events page, located within the Investors & Media section, of the Company’s website at http://ir.tgtherapeutics.com/events.
ABOUT TG THERAPEUTICS
TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.
BRIUMVI® is a registered trademark of TG Therapeutics, Inc.
CONTACT:
Investor Relations
Email: ir@tgtxinc.com
Telephone: 1.877.575.TGTX (8489), Option 4
Media Relations
Email: media@tgtxinc.com
Telephone: 1.877.575.TGTX (8489), Option 6
FAQ
When will TG Therapeutics CEO Michael S. Weiss speak at the TD Cowen summit (TGTX)?
How can investors watch the TG Therapeutics (TGTX) fireside chat on November 12, 2025?
What are the dates of the TD Cowen Immunology & Inflammation Summit where TGTX will present?
Who from TG Therapeutics will participate in the TD Cowen Immunology & Inflammation Summit?
Will TG Therapeutics provide a replay of the TGTX fireside chat if I miss the live webcast?
Where is the TG Therapeutics (TGTX) webcast hosted for the November 12, 2025 fireside chat?
